Furosemide description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Furosemide

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

Furosemide is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. Therefore, careful medical supervision is required and dose and dose schedule must be adjusted to the individual patient's needs. (SeeDOSAGE AND ADMINISTRATION.)

FUROSEMIDE DESCRIPTION



Furosemide





CLINICAL PHARMACOLOGY







Geriatric Population
PRECAUTIONS: Geriatric Use

INDICATIONS & USAGE

Edema


Hypertension


FUROSEMIDE CONTRAINDICATIONS



WARNINGS





PRECAUTIONS

General









INFORMATION FOR PATIENTS





LABORATORY TESTS







DRUG INTERACTIONS


















CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY





PREGNANCY

Pregnancy Category C






NURSING MOTHERS




GERIATRIC USE


PRECAUTIONS: GeneralDOSAGE AND ADMINISTRATION

FUROSEMIDE ADVERSE REACTIONS





























































OVERDOSAGE







DOSAGE & ADMINISTRATION


Edema


Adults


PRECAUTIONS: Laboratory Tests

Geriatric Patients
PRECAUTIONS: Geriatric Use

Pediatric Patients


Hypertension


Adults



Geriatric Patients
PRECAUTIONS: Geriatric Use

HOW SUPPLIED















STORAGE AND HANDLING





PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Furosemide

Furosemide

Furosemide TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-566(NDC:0781-1966)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
FUROSEMIDE FUROSEMIDE 40 mg

Inactive Ingredients

Ingredient Name Strength
lactose monohydrate
MAGNESIUM STEARATE
STARCH, CORN

Product Characteristics

Color Size Imprint Code Shape
white 8 mm GG201 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-566-30 400 in 1 CANISTER

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA018569 2011-10-10


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.